These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27011668)

  • 1. Role of National Accreditation Board of Hospitals and Healthcare Providers (NABH) core indicators monitoring in quality and safety of blood transfusion.
    Gupta A; Gupta C
    Asian J Transfus Sci; 2016; 10(1):37-41. PubMed ID: 27011668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An approach to improve patient safety and quality beyond accreditation.
    Sibal A; Uberoi RS; Malani A
    World Hosp Health Serv; 2016; 52(2):10-12. PubMed ID: 30716235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the Key Performance Indicator Proposed by NABH in the Blood Centre of a Tertiary Health Care Hospital in Southern India.
    Gnanaraj J; Kulkarni RG; Sahoo D; Abhishekh B
    Indian J Hematol Blood Transfus; 2023 Apr; 39(2):308-316. PubMed ID: 37006976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of transfusion quality indicators as a tool for hemovigilance system implementation at a tertiary care center in Saudi Arabia.
    Hindawi SI; Badawi MA; Raj ET; Gholam KA; Al-Weail SO; Azher F
    Saudi Med J; 2016 May; 37(5):538-43. PubMed ID: 27146617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality indicators for the hospital transfusion chain: a national survey conducted in 100 dutch hospitals.
    Zijlker-Jansen PY; Janssen MP; van Tilborgh-de Jong AJ; Schipperus MR; Wiersum-Osselton JC
    Vox Sang; 2015 Oct; 109(3):287-95. PubMed ID: 25898854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How is national recipient hemovigilance conducted in the United States?
    Chung KW; Harvey A; Basavaraju SV; Kuehnert MJ
    Transfusion; 2015 Apr; 55(4):703-7. PubMed ID: 25565577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion-related adverse reactions: From institutional hemovigilance effort to National Hemovigilance program.
    Vasudev R; Sawhney V; Dogra M; Raina TR
    Asian J Transfus Sci; 2016; 10(1):31-6. PubMed ID: 27011667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality indicators for Transfusion Medicine in Spain: a survey among hospital transfusion services.
    Romon I; Lozano M
    Blood Transfus; 2017 May; 15(3):207-214. PubMed ID: 27483486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Study of the Utility of Vertical Quality Audits in a Blood Transfusion Centre as a Quality Improvement Tool: Comparison and Differences between Vertical and Horizontal Audits.
    Desai KN; Bhatt PS; Maru AK; Shaik RA
    Maedica (Bucur); 2022 Jun; 17(2):387-394. PubMed ID: 36032589
    [No Abstract]   [Full Text] [Related]  

  • 11. Retrospective evaluation of adverse transfusion reactions following blood product transfusion from a tertiary care hospital: A preliminary step towards hemovigilance.
    Kumar P; Thapliyal R; Coshic P; Chatterjee K
    Asian J Transfus Sci; 2013 Jul; 7(2):109-15. PubMed ID: 24014939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.
    Haass KA; Sapiano MRP; Savinkina A; Kuehnert MJ; Basavaraju SV
    Transfus Med Rev; 2019 Apr; 33(2):84-91. PubMed ID: 30930009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of Transfusion Related Adverse Reactions in a Tertiary Care Centre in Bangalore: A 4-Year Hemovigilance Initiative.
    Pai S
    Indian J Hematol Blood Transfus; 2020 Oct; 36(4):733-739. PubMed ID: 33100718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion reaction reporting in the era of hemovigilance: where form meets function.
    Dunbar NM; Walsh SJ; Maynard KJ; Szczepiorkowski ZM
    Transfusion; 2011 Dec; 51(12):2583-7. PubMed ID: 21745209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical indicators in accreditation: an effective stimulus to improve patient care.
    Collopy BT
    Int J Qual Health Care; 2000 Jun; 12(3):211-6. PubMed ID: 10894192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Assessment of Nursing Care Regarding Hemovigilance in Neonatal Wards and Neonatal Intensive Care Units in Selected Hospitals Affiliated to Shahid Beheshti University of Medical Sciences (2013 - 2014).
    Tajalli S; Nourian M; Rassouli M; Baghestani AR
    Iran Red Crescent Med J; 2015 Jul; 17(7):e19987. PubMed ID: 26421167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the Accreditation Program of the Saudi Central Board for Accreditation of Healthcare Institutions on the Safety Dimension of the Institute of Medicine Quality.
    Alsaedi A; Sukeri S; Yaccob NM; Almazroea A
    J Multidiscip Healthc; 2023; 16():1179-1190. PubMed ID: 37143479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of mandating a dedicated hemovigilance nurse and objectification of 'imputability' levels. Experience from a hospital-based blood centre in India.
    Dhiman Y; Raturi M; Kala M; Kusum A
    Transfus Clin Biol; 2023 Feb; 30(1):96-102. PubMed ID: 36162622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving safety in blood transfusion using failure mode and effect analysis.
    Mora A; Ayala L; Bielza R; Ataúlfo González F; Villegas A
    Transfusion; 2019 Feb; 59(2):516-523. PubMed ID: 30609064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.